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Bound metals are observed in a great many natural proteins, where they perform diverse roles in 
determining protein folding, stability and function. Due to the diverse impact of bound metals on 
biophysical and biochemical properties of proteins, it is valuable to have accurate and facile methods for 
determining the metal content of proteins. Here we describe an optimized methodology using 4-(2-
pyridylazo)resorcinol (PAR) to simultaneously quantify two metal ions in solution. The assay is 




 ions in human Cu, Zn superoxide dismutases (SOD1s); 
however, the method is general and can be applied to various combinations of metal ions. Advantages 
of the assay are that it is rapid and inexpensive, requires little sample and preparation, and has simple 





 with high accuracy and precision.  Using the PAR assay, we determined that metal 
binding is altered in disease-associated mutants of SOD1, with comparable results to those determined 
by ICP-AES. In addition, we highlight key issues for using spectrophotometric chelators such as PAR for 
metal analysis of proteins.  
KEYWORDS (max 6 keywords) 
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LIST OF ABBREVIATIONS 
A500, absorbance at 500 nm; AAS, atomic absorption spectroscopy; ALS, amyotrophic lateral sclerosis; 
DSC, differential scanning calorimetry; EDTA, ethylenediaminetetraacetic acid; GdnHCl, guanidine 
hydrochloride; ICP-AES, inductively coupled plasma atomic emission spectroscopy; ICP-MS, inductively 
coupled plasma mass spectrometry; Kd, dissociation constant; NTA, nitrilotriacetic; PAR, 4-(2-
pyridylazo)resorcinol; PAR:Cu
2+




, PAR with bound Zn
2+
; pWT, pseudo 
wild-type SOD1 double mutant used as the control protein; SOD1, human Cu, Zn superoxide dismutase; 
SpLab, spectral decomposition software; Tm, temperature where half of the protein is unfolded; Zincon, 
2-carboxy-2’-hydroxy-5’-sulfoformazylbenzene; λmax, wavelength of maximum absorption 





















1. Introduction  
 Bound metals are found in approximately one third of all natural proteins [1], in diverse 
structural contexts and functional roles [2]. Measurement of the metal content of proteins is 
complicated by various factors including the complex structure of proteins, which may interfere with 
quantification, and the generally limited quantities of metal ions in protein samples.  For these reasons, 
selective and sensitive methods are required. Well-known detection methods for metal determination in 
proteins include atomic absorption spectroscopy (AAS), inductively coupled plasma atomic emission 
spectroscopy (ICP-AES) and inductively coupled plasma mass spectrometry (ICP-MS). In general, these 
methods are accurate and reliable but they are typically time-consuming, costly, and are not always 
easily accessible [3–5].  
 
Alternative methods for quantitating metal ions in metalloproteins make use of chromophores 
exhibiting altered spectral properties upon metal binding, such as 2-carboxy-2’-hydroxy-5’-
sulfoformazylbenzene (Zincon) and 4-(2-pyridylazo)resorcinol (PAR) [6–10]. These chromogenic 
chelators are inexpensive, fast and easy to use, and sensitive but are often not very selective [11,12] . 
Due to the low selectivity, their use in metal determination has commonly been restricted to samples 
containing just one metal ion [13–15]. Still, various methods have been reported for the simultaneous 
quantitation of two metal ions in solution [6,8–10]. One widely cited method uses PAR in combination 
with two additional chelators, ethylenediaminetetraacetic acid (EDTA) and nitrilotriacetic acid (NTA), to 
sequentially spectroscopically silence metals allowing for their quantitation [9]. We investigate the 
accuracy of this method herein, identifying inaccuracies arising from the limited specificity of the 
chelators.  
 
Building on these earlier spectrophotometric assays [6,8,9], we have developed a facile, reliable, 




 in solution. The 
multicomponent PAR assay described herein uses spectral decomposition software to deconvolute the 
absorbance contributions of different species in solution allowing for high accuracy and precision in 









). We determine optimal assay solution 
conditions and highlight important experimental considerations for using the PAR assay to analyze 
metalloproteins. The assay methodology is general and may be applied to the study of many proteins 














We demonstrate the utility of the developed multicomponent PAR assay by using it to analyze 
the human metalloenzyme, Cu,Zn superoxide dismutase1 (SOD1).  This widely studied model protein is 
implicated in causing the common and invariably fatal neurodegenerative disease amyotrophic lateral 
sclerosis (ALS) [16].  Many chemically and structurally diverse mutations in SOD1 contribute to onset of 
ALS [17], yet little is known about metal binding by these mutant proteins.  Initial studies provide 
evidence for weakened affinity and selectivity of metal binding for some mutants  [9,18–20] and for 
enhanced neurotoxic misfolding and aggregation of SOD1 in the absence of full or correct metal 















dynamics of SOD1 [1,22,23], as for other proteins [1,2,24]. Thus, this paper illustrates the value of the 
multicomponent PAR assay approach for facile and accurate metal quantification of proteins. 
 




All solutions were prepared using Milli-Q ultrapure water (18.2 MΩ·cm; Millipore Ltd., Bedford, 
MA). which was confirmed by ICP-MS to have < 0.03 ppt Cu
2+
 and < 0.77 ppt Zn
 2+
. All glassware, pipette 
tips, Eppendorf tubes and cuvettes were washed with nitric acid (50% (v/v) followed by Milli-Q water to 




 were prepared by 
dissolving the appropriate amount of CuSO4·5H2O and ZnCl2 in water using a volumetric flask. Working 
metal stock solutions (0.25 mM) were prepared volumetrically by further dilution with water. A 
guanidine hydrochloride (GdnHCl; CH5N3·HCl) stock solution (8 M) was prepared by dissolving the 
denaturant in water to a final volume of 300 mL and determining the concentration by refractive index 
[25]. Stock solutions (80 mM) of ethylenediaminetetraacetic acid (EDTA; C10H14N2O8Na2·2H2O) and 
nitrilotriacetic acid (NTA; C6H9NO6) were prepared by dissolving the appropriate amount of chelator in 
water. Sodium hydroxide (NaOH; 16mM) was added to the NTA solution. 
  
A stock solution of PAR (10 mM) was prepared by dissolving the chelator (Sigma Aldrich; 98% 
purity) in water. Working 4x PAR stock solutions were prepared by combining the appropriate amount 
of the PAR stock solution (final sample PAR concentration of 100 μM unless otherwise stated) with 2.12 
g of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; C8H18N2O4S) and water to a final volume 
of 40 mL. The pH of the 4x PAR solution was adjusted to 8.0 using 1 M NaOH. A final assay volume of 
500 μL was comprised of 1x PAR, 5.4 M GdnHCl, and 50 μL of the solution being analyzed (which may be 
a protein solution or a stock metal) and was measured to have a pH of 8.2 with a standard electrode. As 
PAR deteriorates when exposed to light and in glass bottles, all PAR solutions were stored in plastic 
conical vials covered in aluminum foil at 4°C to minimize degradation. 
 
2.2. Preparation and purification of recombinant SOD1 
All variants of SOD1 are in the pseudo wild-type (pWT) background, a variant of SOD1 in which 
the two free cysteines at position 6 and 111 have been mutated to alanine and serine, respectively, to 
prevent formation of aberrant intermolecular disulfide bonds. pWT has been characterized extensively 
and exhibits essentially the same stability, enzymatic activity and structure as WT SOD1 [19,22,23]. 
Recombinant pWT and mutant SOD1s were expressed as described previously using shaker flask 
cultures [26,27] or fed-batch fermentation [28].  In the expression system used, SOD1 is exported to the 
periplasm from which it is obtained by osmotic shock for shaker flask cultures, or from the culture 
supernatant of fermentation cultures using ammonium sulfate (40% w/v) precipitation. Then SOD1 
variants were purified using a modification of the procedure of Getzoff et al. with Poros HP2 




















 [29].    
2.3. Sample preparation and measurement 
For metal determination, 450 μL of the 1x PAR solution was mixed with 50 μL of sample solution 




 or both). For protein metal determination, the 
protein (50 μL) was first added to GdnHCl (337.5 μL) and incubated for 40 minutes to allow sufficient 
time for the protein to unfold. Then the 4x PAR solution was added (112.5 μL) and the sample was 
thoroughly mixed using a micropipette. The final assay solution conditions were 100 μM PAR, 50 mM 
HEPES (pH 8.2) and 5.4 M GdnHCl, unless otherwise stated. In all cases, absorbance scans were 
measured from 200 nm to 800 nm at room temperature on a Cary 300 UV-Visible spectrometer (Agilent 
Technologies) using a cuvette with a 1 cm pathlength. Throughout the paper, replicate measurements 
refer to measurements of multiple samples within one experiment. 
The preparation and measurement of samples for metal determination using the Crow method 
were performed as described in Crow et al., 1997 [9] with the exceptions that HEPES buffer (50 mM) 
was used instead of sodium borate buffer (100 mM) and the final sample pH was 8.2 instead of 7.8. 
Trace background metals were accounted for by subtracting observed decreases in absorbance at 500 
nm upon the addition of NTA and EDTA in the absence of added metal. Dilution upon the addition of 
EDTA and NTA was not accounted for as the effect on calculated metal content was minimal (≤ 1.5%).   
2.4. Spectral fitting method (SpLab) 
 For metal quantitation using the multicomponent PAR assay, the spectral decomposition 
software SpectraLab or SpLab (created by Dmitri Davydov, Washington State University, [30]) was used 
to determine the absorbance contributions of different species in solution (Figure A.1). SpLab is freely 
available for download (http://cyp3a4.chem.wsu.edu/spectralab.html). With SpLab, spectral 
decomposition is achieved using the linear least squares method to minimize the sum of the squared 
deviations (residuals) between the observed absorbance and the fitted value. Using this software, the 
experimental spectrum is fit as a linear combination of three absorbance standards: free PAR, PAR:Cu2+ 
and PAR2:Zn
2+
. The concentration of each metal in the sample is calculated from the fraction of each 
standard spectrum in the fitted spectrum, which is determined from the weighting coefficient in the 
SpLab output.  
 For the multicomponent PAR assay, the experimental absorbance spectrum of the sample, A, is fit as: 
 = 	
 +		 +																																																																																						. 1 
where Componenti = wi x Standardi.  The wi and Standardi correspond to the weighting coefficient and 
standard spectrum for component i, respectively, and Standard1, Standard2 and Standard3 are the 
spectra for 100 µM PAR, 10 µM Cu2+ in 100  µM PAR, and 10 µM Zn2+ in 100  µM PAR, respectively. The 















Additional details for using SpLab are given in the legend of Figure A.1. Note that principal component 
analysis is also available in SpLab and can be used for spectral deconvolution. However, for lower metal 
concentrations or noisy spectra using the abovementioned fitting routine with a set of standard spectra 
gives more accurate and reliable results 
2.5. Analysis of the accuracy and precision of the PAR Assay  
  





were analyzed, comparing the agreement between the expected and calculated values for each metal. 
In addition, the metal content of protein samples analyzed by ICP-AES and the PAR assay were 
compared. ICP-AES is a sensitive metal quantitation method with a detection limit < 1 ppb. Protein 
samples (0.3 mM to 0.5 mM; 300 μL) were diluted to 3 mL using Milli-Q water prior to analysis by ICP-
AES. The precision of the PAR assay was assessed by measuring the average and standard deviation for 
samples prepared in triplicate (unless otherwise stated).  
2.6. Differential scanning calorimetry 
 Differential scanning calorimetry (DSC) of SOD1 was performed to assess protein stability and 
metalation as described previously [27,31,32], using a LLC VP-DSC instrument (MicroCal Inc., Malvern 
Instruments Ltd.). SOD1 samples (0.2 – 1.0 mg mL
-1
) were buffered in 20 mM HEPES at pH 7.8.  
Buffer/buffer baselines were determined for each experiment and subtracted from protein/buffer scans. 
Data were normalized for protein concentration. Experiments used a scan rate of 1 °C min
-1
. 
3. Results and Discussion  
 
3.1. Extinction coefficients  
 
The free PAR absorption spectrum exhibits a symmetric peak with a maximum absorption (λmax) 
at 416 nm (Figure 1A). Upon metal binding, the absorbance at 416 nm decreases and a shoulder appears 
at approximately 500 nm. The λmax and shape of the shoulder are dependent upon the identity of the 
bound metal (Figure 1A). The molar extinction coefficients of the PAR:Cu2+ and PAR2:Zn
2+ complexes, 













, respectively. This measured Cu
2+
 extinction coefficient closely matches the 
previously reported value [9]. The extinction coefficient for Zn
2+
 is comparable to values reported 
previously [6,9,33]; we note though that this extinction coefficient is sensitive to solution conditions 
such as pH [9,33] and the binding stoichiometry of PAR and Zn
2+
, which can switch from 2:1 to 1:1 under 
certain solution conditions (see 3.2.). Fitting the absorption spectra of various combinations of Cu
2+
 and 
Zn2+ with PAR (Figure 1C) demonstrates that the observed spectra correspond to a linear combination of 




 spectra, which can be leveraged to simultaneously quantitate two 





















 for the PAR assay. (A) 
Absorption spectra of 100 µM PAR in the absence of added metal and with addition of 10 μM Cu2+ or Zn2+. (B) 




 at 500 nm. Extinction coefficients corresponding to the slopes of the lines 












, respectively. (C) 




 in 100 µM PAR with the total metal 




 (μM).  
 
3.2. Optimization of assay solution conditions 
 
In developing the multicomponent PAR assay, we first considered the optimal PAR 
concentration to use. Previous metal quantitation assays using PAR have the chromogenic chelator 
concentration in the range of 50 to 100 μM [6,8,9]. When deciding what concentration of PAR to use it is 
important to consider the effect of the chelator concentration on the stoichiometry of metal binding. 
Previous investigations suggest that PAR and Zn
2+















2.5-fold molar excess over Zn
2+ 
[9]. This is illustrated by analysis of Zn
2+
 standard curves at 50 μM and 
100 μM PAR (Figure 2A). When the PAR concentration is 50 μM, there is a clear deviation from linearity 
at Zn
2+
 concentrations of 15 μM and higher, indicative of a change in the binding stoichiometry once PAR 
is no longer in 2.5-fold molar excess. When the PAR concentration is 100 μM, the curve remains linear at 
all Zn
2+
 concentrations studied, up to 25 μM Zn
2+
. On the other hand, PAR and Cu
2+
 appear to form a 1:1 
complex at both 50 and 100 μM PAR, as evidenced by the high degree of linearity for both standard 
curves (Figure 2B). Based on these results, the concentration of PAR used herein was chosen to be 100 
μM with the total metal concentration in samples not exceeding 25 μM to avoid changes in the binding 
stoichiometry of PAR and Zn
2+
 and to therefore stay within the range of linearity.  
 
Figure 2. Metal standard curves in 50 μM and 100 μM PAR. (A) Zn
2+
 standard curve (0 – 25 μM). In the 50 μM PAR 
condition, there is a clear deviation from linearity indicative of a change in the binding stoichiometry of PAR and 
Zn
2+ 




 standard curve (0 – 25 μM). Plotted values are for 
measurements of a single sample. The Cu
2+
 standard curve remains linear at all Cu
2+
 concentrations studied in both 
the 50 μM and 100 μM PAR condition. In panels A and B data are offset to zero absorbance for zero added metal.  
The dotted lines are to guide the eye and correspond to interpolated data values.     
 
3.3. Fitting with SpLab: Standard spectra  
As described earlier, the unique spectral properties of different metals complexed with PAR can 
be exploited to simultaneously quantitate two metals in solution [6,8]. With SpLab, spectral 
decomposition is achieved using the linear least squares fitting method. Using this software, an 
experimental spectrum was fit by a set of three standard spectra representing the three absorbing 




 (Figure 1A). The concentration of the PAR 



















 standard spectra were 
determined by fitting samples of known metal concentrations with standards having concentrations 
ranging from 5 – 25 μM. This represents the range where the change in absorbance is large but 
accurately measurable and is proportional (i.e. linear) to the amount of metal in solution (see above). 
From analyzing both the correspondence to expected values and standard deviation between multiple 
samples within one experiment, we found that fits using absorption standards of 10 μM Cu2+ and 10 μM 
Zn
2+
 gave the most accurate values with the lowest uncertainties. The final fitted spectrum is a linear 





 standard spectra each multiplied by a weighting coefficient.  The concentration 
of each metal ion in solution is obtained by multiplying the weighting coefficient for the corresponding 
component spectrum by the concentration of the original standard spectrum (see Figure 3 legend). 
 
 
Figure 3. Example of multicomponent PAR assay analysis using SpLab. Experimental spectrum (solid green line) of 
sample containing 20 μM Cu
2+
 and 5 μM Zn
2+
 and the three fitted components determined by SpLab (dashed lines) 
sum to  the fitted spectrum (black dotted line) which very closely matches the experimental spectrum (r
2
 0.99).The 
very small residual between the experimental and fitted spectra  is shown with 10-fold increased scale (solid grey 
line). Component spectra were calculated using the weighting coefficients determined from the fit of the 
experimental spectrum by the three standard spectra, illustrated in Figure 1A. The weighting coefficients of 
component1 (PAR), component2 (PAR:Cu
2+
) and component3 (PAR2:Zn
2+
) in the fitted spectrum are -1.5, 2.0 and 




are calculated to be 20.0 μM and 4.90 μM, 
respectively, in excellent agreement with the known concentrations.    
 
3.4. Protein analysis: denaturation, sample measurement and concentration  









M, respectively [9,34]), proteins should be unfolded during the PAR 















The time required for unfolding depends on the strength of the denaturant as well as the stability of the 
protein. Two chemical denaturants commonly used to unfold proteins are urea and GdnHCl. For time 
efficiency, and to ensure that even very stable proteins can be assayed using this method, the PAR assay 
described herein uses the stronger denaturant, GdnHCl [35]. Under these assay conditions (8 M 
GdnHCl), even extremely stable proteins may be fully unfolded; for example,  fully metalled SOD1, which 
has a melting temperature of approximately 92°C, will globally unfold within 40 minutes [31]. As SOD1 
unfolds particularly slowly [19,36], this timeframe is likely to be sufficient to fully unfold most proteins 
[19]. To ensure complete unfolding for even more stable proteins, longer times and/or higher 
concentrations of GdnHCl could be used (noting that the logarithm of the rate constants of unfolding 
generally increases linearly with denaturant concentration [35] ).       
Another important consideration for the success of this assay is the stability of PAR in solution, 
as it has been shown that PAR is sensitive to light [37].  Previously reported methods call for successive 
scanning of the sample to monitor changes in absorption as a function of time [8,9]. To investigate the 
effect of such scanning, we measured the absorbance (200-800 nm) of PAR2:Zn
2+
 (100 µM:10 µM) for 5 
successive scans (each scan ~40 s). After 5 scans the absorbance of PAR2:Zn
2+
 at λmax  (495 nm)  
decreases by 0.01 Abs units, which corresponds to approximately 0.15 μM Zn
2+
 (or 1.5% of the total 
Zn2+). While this value is relatively small, continued scanning for longer times or for samples with lower 
metal concentrations would increase the error. Based on these results, and to avoid photodamage of 
the PAR, we suggest that proteins first be incubated in GdnHCl for 40 min to allow for complete 
unfolding before adding PAR. After unfolding, the protein/GdnHCl solution should be mixed with the 4x 
PAR solution just prior to sample measurement. Previous studies have shown that the binding of metals 
(e.g. Zn
2+
) by PAR is rapid and usually complete within 2 to 3 ms, therefore a long incubation period with 
PAR is not necessary [13].  
We also explored suitable protein concentration for the analysis. The protein concentration 
needs to be high enough to produce a measurable change in absorbance yet low enough to satisfy the 
constraint that the amount of free PAR be in at least 2.5 molar ratio relative to the total metal in 
solution (Figure 2). Also, remembering that PAR binds Zn
2+
 with a 2:1 stoichiometry, Zn
2+
 will remove 
twice as much free PAR as Cu
2+
. In the case of SOD1, which binds one Cu
2+
 and one Zn
2+
 ion per 
monomer, protein concentrations ranging from 1 to 9 μM (SOD1 monomer) will satisfy these constraints 
(assuming SOD1 is fully metallated and a starting concentration of 100 μM PAR). Protein concentrations 
within this range were tested and had very little effect on the accuracy and precision of the assay, 
defining a suitable protein concentration range for the assay.  For further experiments described below, 
a final protein concentration of 5 μM was used.  
3.5. Determination of the accuracy and precision of the SpLab PAR Assay  
To assess the accuracy and the precision of the multicomponent PAR assay, a variety of samples, 
without and with protein (5 µM), containing known amounts of Cu2+ and Zn2+ were tested. Analysis of 




 in the absence of protein are given in Table 1. In every 
case the expected and calculated metal concentrations are within 5%, and, the standard deviation is 















deconvolute the spectral signals of the three absorbing species in solution with high accuracy and 
precision.  Samples containing increasing concentrations of individual metals were also tested to ensure 
that the data could be fit accurately in the absence of the other metal and showed excellent agreement 
between known and measured concentrations (Figure A.2 and Table A.1).  




 in solution 
using the multicomponent PAR assay 














0.0 25.0 0.2 ± 0.2 24.9 ± 0.3  - 99 ± 1 
5.0 20.0 4.9 ± 0.3 20.9 ± 0.5 98 ± 7 104 ± 2 
10.0 15.0 9.7 ± 0.3 15.3 ± 0.1 97 ± 3 102 ± 1 
15.0 10.0 15.1 ± 0.3 10.2 ± 0.0 101 ± 2 102 ± 0 
20.0 5.0 20.3 ± 0.1 5.1 ± 0.0 101 ± 1 101 ± 0 
25.0 0.0 24.9 ± 0.4 0.0 ± 0.1 99 ± 2 - 
Each value represents the mean ± the standard deviation of measurements on three replicate samples within 
one experiment. The percent (%) metal was calculated as ([calculated metal] / [known metal])*100%.  
 
 We also assessed the accuracy and precision of this assay in the presence of protein to ensure 
that protein does not interfere with the results. As an independent measure of metal content, ICP-AES 
was used to determine the metal content of two SOD1 variants with distinctly different metalation 
properties, pWT and the ALS-associated mutant, H46R. H46 coordinates bound Cu2+ in pWT and upon its 
mutation to R the protein is unable to bind Cu
2+
 at the native Cu
2+
 site [38]. H46R has decreased thermal 
stability compared to pWT and one of the longest disease durations among all ALS-associated mutations 
[39,40]. The results show that the metal concentrations determined using ICP-AES and the PAR assay for 
pWT and H46R are in excellent agreement (Table 2). This provides further evidence that the PAR assay 
described herein can quantitate the metal ion content of metalloproteins with high accuracy.  
 
Table 2. Metalation of SOD1 measured by multicomponent PAR assay and ICP-AES 
SOD1 sample 














pWT  0.82 ± 0.01 1.11 ± 0.02 0.82 1.08 0.00 0.03 
H46R  0.0 ± 0.0 1.04 ± 0.03 0.02 1.11 0.02 0.06 
All SOD1 samples were purified from fermenter cell cultures (see 2.2s, with no exposure to EDTA (see 3.7). SOD1 
concentrations for PAR assay were 5 µM monomer. For ICP-AES, 3 mL of 30 µM monomer protein was analyzed 
(see Methods). Values are calculated as fraction metal per protein subunit, where full metalation corresponds to 
1.00. The differences are calculated as the absolute value of fraction metal PAR - fraction metal ICP-AES. The two 
methods are in very close agreement. ICP-AES analysis was completed at the Analytical Laboratory for 


















3.6. Analysis of previous PAR assay method for metal quantification  
For comparison, we also investigated the accuracy and precision of a previously reported, 
extensively cited PAR assay methodology [9].  The PAR assay protocol developed by Crow et al. employs 
two chelators, NTA and EDTA. In this assay, PAR is used to bind Cu and Zn released by SOD1 unfolded in 
GdnHCl.  Next, NTA is added with the associated change in A500 attributed to the quantitative removal of 
Zn from PAR by the NTA . A further change in A500 occurs with the subsequent addition of EDTA and is 
attributed to the quantitative removal of Cu from PAR by EDTA.  Thus, this method assumes specific 
removal from PAR of Zn
2+
 by NTA and of Cu
2+
 by EDTA. 





. The results reveal significant errors for a range of sample conditions 
(Table A.2). For example, when the concentration of Zn
2+
 is 4-fold greater than the concentration of 
Cu
2+
, the error especially for Cu
2+
, is largest (215% compared to the expected 100%). When the 
concentration of Zn
2+
 is smaller than Cu
2+
 or the concentrations of both metals are equal, the error is 
reduced but still significant (88-128%). In almost every case the multicomponent PAR assay described 
herein gives significantly lower error than that observed for the Crow methodology (Figure 4).  
 
 
Figure 4. Comparison of the accuracy of the Crow and multicomponent PAR assay methods. The symbols for 
the different methods are given in the legend. The known concentrations of each metal in the sample are given 




 (μM). The % metal compared to known was calculated as ([calculated metal]/[known 
metal]) * 100% for Cu
2+
 (upper panel) and Zn
2+
 (lower panel).  The points are the mean value for measurements 
of 3 or 2 independent samples (PAR and Crow, respectively) with error bars representing 1 SD.  Raw data are in 
















To identify the source of error in the Crow methodology, we investigated the specificities of the 
chelators NTA and EDTA for binding the respective target metals by measuring the associated spectral 





respectively, from PAR. For example, for 20 μM Zn
2+
, NTA does not chelate all of the Zn
2+
 present (Figure 
2A). In fact, even though NTA is in 40-fold excess over Zn
2+
 and 8-fold excess over PAR, the chelator 
binds just 93% of the Zn2+; the remaining 7% of Zn2+ is removed from PAR by the addition of 0.8 mM 
EDTA.  Furthermore, for 20 μM Cu
2+
, there is a small, but clear decrease in absorbance upon the addition 
of NTA, indicating that the chelator is removing approximately 5% of the Cu
2+
 from PAR (Figure 2B). 




 concentrations (5, 10 and 15 μM) with the 
same trend being observed (data not shown).    
 
 




 determination. In 
this assay, the decrease in absorbance at 500nm (ΔAbs500) is converted to the concentration of metal bound by 
each chelator using Beer-Lambert’s law and the corresponding extinction coefficient [9]. (A) Changes in the 
absorption spectrum of PAR  (100 μM) with Zn
2+
 (20 μM) (purple), upon addition of  NTA (0.8 mM) (green) 
followed by EDTA (0.8 mM) (dotted line).The spectral change upon addition of NTA corresponds to removal of 93% 
of the 20 µM Zn2+ from PAR, while EDTA addition removes the remaining 7%. (B) Changes in the absorption 
spectrum of PAR (100 μM) with Cu
2+
 (20 μM), upon addition of NTA (0.8 mM) and then EDTA (0.8 mM). The 
absorbance change upon addition of NTA corresponds to removal of 5% of the Cu
2+





The results of the spectral changes for mixtures of PAR, NTA and EDTA (Figure 5) help explain 
the observed trends in the errors associated with the Crow method (Table A.2 and Figure 4). For 
example, as mentioned earlier, when the concentration of Zn
2+
 is greater than that of Cu
2+

















, is largest. This is because when the concentration of Zn
2+
 is high, NTA does not bind 
all of the Zn
2+
 present leaving the remaining Zn
2+
 to be bound by EDTA. This results in a higher than 
expected Cu
2+
 value and a lower than expected Zn
2+
 value. The error in the Cu
2+
 value is further 
amplified by the fact that the extinction coefficient for the PAR:Cu2+ complex is nearly half that of 
PAR2:Zn
2+
, and therefore any Zn
2+
 misattributed to Cu
2+
 is “counted” approximately twice. On the other 
hand, when the concentration of Zn
2+
 is low relative to Cu
2+
, NTA will bind some Cu
2+
 resulting in a lower 
than expected Cu
2+
 measurement and a higher than expected Zn
2+
 measurement. When the 
concentration of both metals in solution is equal the calculated metal content is more accurate, 
although generally some of the Zn
2+
 is still misattributed to Cu
2+
. Overall, the results show that the type 
and amount of metal bound by NTA is dependent upon the relative concentration of each metal in 
solution. Thus, lack of full specificity by the chelators helps explain the larger errors associated with the 
Crow method compared to the multicomponent PAR assay described herein (Figure 4).  
 
3.7. Application of multicomponent PAR assay: metalation of disease-associated SOD1 mutants  
 Using the multicomponent PAR assay, we investigated the metalation of pWT SOD1 and 9 ALS-
associated mutants. The results indicate that all the proteins appear to be undermetallated (Table 3). On 
average, SOD1 variants contain 0.72 (± 0.18) Zn
2+
 equivalents/monomer and 0.62 (± 0.18) Cu
2+
 









M, respectively [9]), and while mutants may have altered metal binding, 
many have very high activity and stability, which depend on metal binding [9,20,29,34,41]. 
Measurements of SOD1 variants’ stability by differential scanning calorimetry (DSC) (Table 3), which is a 
sensitive reporter of metal binding [31,32], indicates that these samples have higher metalation levels 
than indicated by the PAR assay.  For example, based on the PAR assay pWT has 0.78 Cu
2+
 
equivalents/monomer and 0.89 Zn
2+ 
equivalents/monomer, yet it has a Tm of 91.4°C (Table 3), which is 
comparable to that of fully metallated pWT (92°C) [31]. The presence of protein does not interfere with 
the accuracy or precision of the PAR assay (Table 2), thus the systematically low metalation values for 
























Table 3. Metal-ion content determined by multicomponent PAR assay 





/monomer Tm (°C) 
pWT 0.78 ± 0.01 0.89 ± 0.00 91.41 
A4S 0.72 ± 0.06 0.75 ± 0.05 88.35 
A4V 0.62 ± 0.00 0.74 ± 0.00 86.73 
G41D 0.62 ± 0.03 0.76 ± 0.04 85.74 
G41S 0.65 ± 0.06 0.77 ± 0.05 82.64 
H43R 0.58 ± 0.03 0.76 ± 0.03 85.82 
G85R 0.47 ± 0.03 0.58 ± 0.01 77.46 
G93A 0.66 ± 0.04 0.80 ± 0.05 87.53 
E100K 0.84 ± 0.05 0.78 ± 0.03 89.01 
V148I 0.67 ± 0.01 0.85 ± 0.01 93.07 
All SOD1 samples were prepared from shaker flask cell cultures, with exposure 
to EDTA during initial osmotic shock. Metal values are given as average 
equivalents per monomer ± the standard deviation of measurements of three 
independent samples in one experiment (except A4V which the average of is 
two independent samples). Full metal incorporation is 1 equivalent per 
monomer. The temperature where half of the protein is unfolded, or Tm, was 
measured by DSC.   
 
 Further investigation showed that these results are related to the presence of EDTA bound to 
the SOD1, which partially masks the metal ions.  During the preparation of these SOD1 variants from E. 
coli grown in shaker flasks, EDTA is required in an initial osmotic shock step to ensure release of the 
SOD1 protein from the periplasm [26,32].  EDTA is not used in any of the following purification steps, 
including heat treatment, chromatography, and extensive dialysis. Nevertheless, EDTA is known to bind 
with high affinity to SOD1 [42] and it appears still to be bound to the final sample based on the 
systematically low PAR assay results here (Table 3).  This conclusion is supported by size-exclusion 
chromatography experiments for SOD1 prepared from shaker flask cultures which exhibit a small 
characteristic EDTA peak. As EDTA is commonly added to many buffers to chelate metals and reduce 
protein damage caused by metalloproteases, these results highlight that care should be taken to avoid 
the presence of EDTA when using PAR assays.    
 To confirm that the metalation values in Table 3 obtained using the multicomponent PAR assay 
are indeed erroneously low, we again used ICP-AES to obtain an independent measure of metal content 
for a pWT SOD1 sample (Table 4). It should be noted that the samples initially assessed by ICP-AES 
(Table 2) were prepared from E. coli cells grown in a fermenter, wherein the SOD1 is naturally released 
from the periplasm and no use of EDTA in an osmotic shock step is required; thus, this SOD1 protein is 
never exposed to EDTA during purification (Table 2). Indeed, the metalation values for these samples 
determined by both methods are in excellent agreement, showing the protein does not interfere with 
the PAR assay. However, for protein samples prepared from cells grown in shaker flasks with exposure 
to EDTA, the metal ion content determined by PAR is approximately 20% lower than that determined by 















Taken together, these findings suggest that EDTA does in fact remain bound to SOD1 samples 
prepared using a typical shaker flask cell growth, and that the bound EDTA will mask a proportion of the 
metal present resulting in falsely low numbers. The presence of protein-bound EDTA would also 
interfere with any of the PAR assay methodologies described previously [6,8,9,15]. The results here 
point out an important potential source of error in this type of methodology which may be commonly 
overlooked. While the presence of EDTA does interfere with the assay, if we assume the amount of 
bound EDTA is relatively constant (as a single stock EDTA solution was prepared and used in the same 
way in osmotic shock during the preparation of all proteins), the results show that in general SOD1 
mutants tend to have overall lower metalation levels than the pWT.  Notably, the metal ion content is 
lowest for the G85R mutant, consistent with its demonstrated markedly weakened metal binding 
compared to the other mutants, which are all considered to be wild-type like with respect to metal 
binding and activity [34].  Also, A4V was suggested to have somewhat decreased Zn affinity [9].  Taken 
together, these results suggest that various SOD1 mutations tend to interfere with proper metalation.  
 
Table 4. Metal content of pWT SOD1 from shaker flask 






PAR 0.70 0.82 
ICP-AES 0.89 1.08 
Difference 0.18 0.25 
Values are calculated as fraction metal per protein subunit, where 
full metalation corresponds to 1.00. The differences are determined 
to be the absolute value from the subtraction of the metal 
concentration determined by ICP-AES from that determined by the 
PAR assay. It should be noted that the pWT sample used here was 
obtained from a different preparation than that in Table 3. ICP-AES 
analysis was performed at Solutions Analytical Laboratory, University 
of Waterloo, Waterloo, Ontario, Canada. 
 
3.8. Considerations for using a spectrophotometric chelator for metal quantitation and other 
applications 
 Use of a spectrophotometric chelator for metal quantitation provides the advantages of low 
cost, high sensitivity and a small time requirement; there are, however, some additional potential issues 
to using PAR that should be addressed. As previously mentioned, PAR is light sensitive [37]. Thus, it is 
important to ensure proper storage of PAR solutions and avoid methodologies that involve prolonged 
light exposure to avoid degradation of PAR. PAR has also been shown to deteriorate significantly over 
short periods of time when stored in glass bottles, regardless of the extent of light exposure [37]. We 
have found that when stored in plastic conical vials in the dark at 4°C, PAR solutions (100 μM or 10 mM) 
can last up to a year with little degradation. Therefore, PAR is relatively stable under suitable conditions.  
The possibility of contaminating metal-binding species must also be considered when using the 
PAR assay.  An example of this is found in Section 3.7 wherein previously unidentified protein-bound 
EDTA proved to be an issue in analysis of SOD1 samples. Any contaminating species with affinity for the 















contaminating species: buried, protein-bound metals are less likely to be bound by the PAR, interfering 
with the assay. Since the unfolding rate of proteins generally has a logarithmic dependence on the 
GdnHCl concentration, for extremely stable proteins a higher concentration of the denaturant may be 
needed to successfully overcome this consideration.  
The method described herein may be adaptable to a variety of applications. For example, 
colorimetric methods are commonly employed for automated and high-throughput analysis. To be 
suitable for high-throughput measurements, the assay should ideally be fast and low cost, sensitive so 
that minimal sample is required, in a format to facilitate measuring large numbers of samples, and 
preferably use common, easily-accessible lab equipment, such as a spectrophotometer.  Thus, Hogbom 
and coworkers developed a high-throughput, multi-step, luminol/PAR assay for metal detection and 
single metal identification in 384-well plates, suitable for proteomics applications [15]. While the PAR 
assay described herein is not applicable to complex biological samples containing many different 
proteins and metals in low amounts, it could be useful for the rapid measurement of large numbers of 
samples as it has relatively low protein requirements ( e.g. ~5 µM SOD1 monomer at 500 µL here, or 
~100 µL in plates, ~40 – 8 µg), can be completed in under an hour, and may be optimized for a multi-
well plate format.  We caution that care should be taken for such applications to ensure sufficient signal 
in smaller sample volume wells to accurately measure the different metals.  Also, the PAR method may 


















 employed herein [6,14,33].  Diverse proteins, from enzymes to chaperones and structural proteins 
containing metals bound as individual ions or in clusters, may be amenable to analysis with the PAR 
method, when suitably denatured as described here in 8M GdnHCl to release metal.  Thus, the method 
developed here may be valuable for a range of analyses for purified proteins.  
4. Conclusions  
We report herein a spectrophotometric method for the simultaneous quantification of multiple 
bound metals in proteins using the chromogenic chelator PAR. This method provides the advantages of 
being sensitive, facile, and low cost. Its application to the quantification of Cu2+ and Zn2+ in the 
metalloprotein SOD1 yielded a comparable accuracy to ICP-AES. This multicomponent PAR assay uses 
the spectral software SpLab [30] to perform spectral decomposition based on the signals of the three 




). Analysis simply requires the input of three 
standard absorption spectra at one set of solution conditions.  The SpLab software is freely available and 
easily applied; other data fitting routines for similar or principal component analysis could alternatively 
be used, such as MS Excel or MATLAB.  The developed method is versatile as changes to the 
experimental conditions can be simply accounted for in the standard spectra used for data fitting. Thus, 
the methodology is adaptable to other buffers, sample concentrations, or metals with distinguishable 
spectral signatures. In conclusion, the multicomponent PAR methodology developed here provides 


















Figure A.1: SpLab software screenshot.  
Figure A.2 Quantification of a Single Metal Species with PAR 
Figure A.3. Specificity of the chelators used in previous PAR assay for simultaneous Cu2+ and Zn2+ 
determination. 
Table A.1.  Quantification of a Single Metal Species: Determination of Cu2+ and Zn2+ in solution using 
PAR assay protocol 




 in solution using a 
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Figure A.1 - Screenshot of SpLab software [30]. Experimental data should be saved as a comma delimited (*.csv) file in Excel. 
Multiple spectra can be saved in one file by having the experimental data arranged by column. For analysis, absorbance data 
from 300 nm to 600 nm is used. When SpLab is open (large right panel), under the “File” tab select “Load ASC, CSV or DAT 
File…” to load the experimental data into the program. Select the row which represents the spectrum you would like to fit and 
under the Data Analysis tab there is an option for “Spectral Decomposition”. This will open the SurFit window (bottom middle 
panel) where one can select the standard spectra (by row) for fitting the experimental spectrum and the destination for the 
fitted curve. The order of the polynomial should be set to 0. Upon clicking ‘run’ a SpectraLab window will appear (bottom left 
panel) which gives the fraction (weighting coefficients) of each standard spectrum in the fitted spectrum. The quality of the fit is 
also given in this window by the squared correlation coefficient. The standard spectra of 100 μM PAR, PAR:Cu (10 μM) and 
PAR2:Zn (10 μM) are shown in the upper left panel in black, teal and green, respectively. The experimental spectrum is shown in 
purple (15 μM Cu
2+
, 10 μM Zn
2+
). The fitted spectrum is also plotted but is not visible as it lies directly under (i.e. is effectively 

















Figure A.2 Quantification of a Single Metal Species with PAR. Experimental spectra for samples of increasing known 
concentrations of Cu
2+
 (A) or Zn
2+




















 determination. In 
this assay, the decrease in absorbance at 500nm (ΔAbs500) is converted to the concentration of metal bound by each 
chelator using the Beer-Lambert law and the corresponding extinction coefficient [9]. (A),(B), and (C) Changes in the 
absorption spectrum of PAR  (100 μM) with Cu
2+
 (5 μM, 10 μM and 15 μM, respectively), upon addition of  NTA (0.8 
mM) (green) followed by EDTA (0.8 mM) (dotted line). (D), (E), and (F) Changes in the absorption spectrum of PAR (100 
μM) with Zn
2+





















 in solution using PAR 
assay protocol 














5.0 0.0 4.98 0.068 99.5%  
10.0 0.0 10.00 0.000 100.0%  
15.0 0.0 15.03 0.006 100.2%  
20.0 0.0 20.05 0.029 100.3%  
25.0 0.0 24.94 -0.097 99.8%  
0.0 5.0 -0.016 5.08  101.6% 
0.0 10.0 0.000 10.00  100.0% 
0.0 15.0 0.119 14.75  98.3% 
0.0 20.0 0.238 19.81  99.1% 
0.0 25.0 0.577 24.40  97.6% 
Experiment was conducted as described, but without the addition of a second metal. Spectral deconvolution routine 




 spectra. The percent (%) metal was calculated as 








 in solution using 
PAR assay protocol with NTA and EDTA (8) 














5.0 20.0 10.8 ± 1.2 15.7 ± 0.8 215 ± 24 78 ± 4  
10.0 15.0 12.8 ± 0.8 13.1 ± 0.2 128 ± 8 88 ± 2 
15.0 10.0 16.6 ± 0.6 8.8 ± 0.1 110 ± 4 88 ± 1 
20.0 5.0 19.4 ± 0.5 5.0 ± 0.1 97 ± 2 100 ± 2 
5.0 5.0 6.4 ± 0.8 4.6 ± 0.2 128 ± 16 92 ± 3 
10.0 10.0 11.5 ± 0.4 9.1 ± 0.2 115 ± 4 91 ± 2 
Each value represents the mean ± the deviation of two independent sample measurements. The percent (%) metal was 
calculated as ([calculated metal] / [known metal])*100%. All samples contained 100 μM PAR, 5.4 M GdnHCl, 50 mM 
HEPES, pH 8.2. These experiments were completed in 20 mM Hepes at pH 8.2, which is comparable to the solution 
















• A multicomponent PAR assay is developed to measure multiple metal ions concurrently  
•  Zn2+ and Cu2+ concentrations in SOD1 samples were determined accurately and precisely 
• ALS-associated SOD1 mutants are found more likely to be under- or mis-metallated  
• Contaminating EDTA limits metal quantitation using 4-(2-pyridylazo)resorcinol (PAR) 
 
